TRDA
Entrada Therapeutics Inc
6.30$
+0.6%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -10.31 | -0.82 | -1.63 | -3.00 | 4.23 | -1.07 | -3.11 | |
| 0.10 | 0.01 | 0.04 | 0.06 | 0.09 | 0.10 | 0.10 | |
| 0.28 | 0.01 | 0.08 | 0.32 | 0.40 | 0.46 | 0.47 | |
| -5.71 | 0.01 | 0.08 | 0.32 | – | – | – | |
| 0.17 | 0.01 | -0.11 | -0.36 | 4.12 | -3.05 | -0.12 | |
| 0.60 | 0.07 | 0.15 | 0.09 | 0.17 | 0.08 | 0.03 | |
| -0.60 | -0.07 | -0.15 | -4.75 | -4.19 | -0.71 | 2.82 | |
| – | – | 6.12 | 0.01 | 0.01 | 0.01 | 0.01 | |
| 0.04 | 1.60 | 9.85 | 0.02 | 0.64 | 2.64 | 0.02 | |
| 16.07 | 0.71 | 8.07 | -7.86 | 0.68 | 0.86 | -0.26 | |
| -10.91 | -0.89 | -1.78 | -3.09 | 4.06 | -1.15 | -3.13 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.